Log In
Print
BCIQ
Print
Print this Print this
 

Anti-dengue nanoviricides (DengiCide, DengueCide)

  Manage Alerts
Collapse Summary General Information
Company NanoViricides Inc.
DescriptionNanoviricides targeting certain regions of the dengue envelope protein structure
Molecular Target
Mechanism of Action 
Therapeutic ModalityNanotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationDengue fever
Indication DetailsTreat dengue and dengue hemorrhagic fever
Regulatory Designation

U.S. - Orphan Drug (Treat dengue and dengue hemorrhagic fever);
EU - Orphan Drug (Treat dengue and dengue hemorrhagic fever)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today